Related Experiment Videos

[The use of klofelin for studying somatotropin secretion in children]

Problemy Endokrinologii
|September 1, 1989
PubMed

Insights

Clonidine reliably stimulates somatotropin (STH) secretion in children, with no significant differences observed between healthy children and those with constitutional growth retardation (CRG). This safe and effective test aids in assessing STH secretion.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Physiology

Background:

  • Assessing somatotropin (STH) secretion is crucial for diagnosing growth disorders in children.
  • Constitutional retardation of growth (CRG) is a common condition requiring accurate diagnostic tools.

Purpose of the Study:

  • To evaluate the efficacy and safety of clonidine as a stimulant for STH secretion in children.
  • To compare STH secretion response to clonidine in healthy children versus those with CRG.

Main Methods:

  • A clonidine stimulation test was administered to 47 children (21 healthy, 26 with CRG) at a dose of 0.15 mg/m2 body surface area.
  • Blood samples were collected to measure STH levels at baseline and at intervals up to 90 minutes post-administration.
  • Observed and recorded any adverse effects of clonidine.

Main Results:

  • Clonidine significantly stimulated STH secretion, with peak levels observed 60-90 minutes after administration.
  • Mean STH secretion peaks exceeded baseline levels more than 8-fold in both healthy and CRG groups.
  • No statistically significant difference in STH secretory response was found between the two groups.
  • Reported side-effects were minimal and transient.

Conclusions:

  • Clonidine is a safe, sensitive, and user-friendly agent for stimulating STH secretion in pediatric populations.
  • The study found no discernible difference in STH secretory capacity between children with normal growth and those with CRG when stimulated by clonidine.

Related Concept Videos